[Red Dwarf Star Virtual Series] Supplying the Fight Against Cancer Using Particle Accelerators at Nusano

#ieee #rising #stars #conference #red #dwarf #series #professional #development #students #young #professionals #virtual #webinar
Share

2024 IEEE Rising Stars Conference team presents

THE RED DWARF STAR VIRTUAL SERIES

Supplying the Fight Against Cancer Using Particle Accelerators at Nusano

Leo Szeto

 

Red Dwarf stars are the smallest and emerging in the universe.  The Red Dwarf events represent the formation and growth of our IEEE Rising Stars Conference. The 2024 IEEE Rising Stars Conference team will be hosting a series of monthly events to show you a glimpse of what we are preparing for the conference. We'll be sharing some professional development and technical content throughout this series, as well as some of the networking experience. Join us on a series of informative and engaging events as we prepare for our large stage at the 2024 IEEE Rising Stars Conference, January 5-7, in Las Vegas at the Tropicana Hotel.

The 2024 IEEE Rising Stars Conference registration is now open! We have an excellent line-up of speakers, sessions, workshops, and a couple surprises. Register now and take advantage of our Super Saver registration discount. Discount expires on November 12th.

Register at: https://ieee-risingstars.org/

 

Leo Szeto, Director of Controls Systems and Electrical Engineering at Nusano

Description:

Radioisotopes have been used in medicine for decades. Doctors use tiny tracers like flashlights to light up areas inside the body, helping them target and treat disease. But today, the supply doesn’t meet the need. Logistical problems with radioisotope production are causing hundreds of thousands of patients in the US from getting the treatments they need to survive. Nusano aims to change the future of the industry by developing a system that will mass-produce radioisotopes at scale, using a breakthrough ion source technology combined with a particle accelerator, turning radioisotopes from scarcity to abundance.



  Date and Time

  Location

  Hosts

  Registration



  • Date: 18 Oct 2023
  • Time: 06:30 PM to 07:30 PM
  • All times are (UTC-07:00) Pacific Time (US & Canada)
  • Add_To_Calendar_icon Add Event to Calendar
If you are not a robot, please complete the ReCAPTCHA to display virtual attendance info.
  • Contact Event Host
  • IEEE Rising Stars Conference Organizing Committee (risingstars@ieee.org)

  • Starts 01 June 2023 12:05 AM
  • Ends 18 October 2023 08:00 PM
  • All times are (UTC-07:00) Pacific Time (US & Canada)
  • No Admission Charge


  Speakers

Leo Szeto Leo Szeto of Nusano

Topic:

Supplying the Fight Against Cancer Using Particle Accelerators at Nusano

Radioisotopes have been used in medicine for decades. Doctors use tiny tracers like flashlights to light up areas inside the body, helping them target and treat disease. But today, the supply doesn’t meet the need. Logistical problems with radioisotope production are causing hundreds of thousands of patients in the US from getting the treatments they need to survive. Nusano aims to change the future of the industry by developing a system that will mass-produce radioisotopes at scale, using a breakthrough ion source technology combined with a particle accelerator, turning radioisotopes from scarcity to abundance.

Biography:

Leo Szeto has served in a wide variety of teams and companies of different sizes, from research groups, start-ups, established companies, and multi-national corporations. After graduating from UCLA, Leo became an Imagineer, creating magic as a Ride Controls Engineer for the Shanghai Disney Resort. A strong believer in the creative potential of everyone, Leo has given numerous talks in the US and China on the “Technical Creative”; People who can dream, design, and execute, with vision and passion. 


Leo is currently the director of Controls Systems and Electrical Engineering at Nusano, a series B funded startup that has is building a first-of-its-kind facility to produce medical radioisotopes at scale, enabling the development of radiopharmaceuticals for personalized cancer therapies.